Latest debt-to-equity ratio
4D Molecular Therapeutics Debt-to-equity ratio
Direct answer
4D Molecular Therapeutics's debt-to-equity ratio is 9.62%.
The verified market snapshot reports 9.62%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 22, 2026.
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 9.62%
Explore related company data
View 4D Molecular Therapeutics's market capitalizationView 4D Molecular Therapeutics's price-to-book ratioView 4D Molecular Therapeutics's return on equityView 4D Molecular Therapeutics's 52-week price rangeView 4D Molecular Therapeutics's revenue growthView 4D Molecular Therapeutics's profit marginView all 4D Molecular Therapeutics key metricsReturn to 4D Molecular Therapeutics profile